Aminopterin in Treating Patients With Refractory Leukemia
Public ClinicalTrials.gov record NCT00003305. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Trial of Aminopterin in Adults and Children With Refractory Acute Leukemia Grant Application Title: A Phase II Trial of Aminopterin in Acute Leukemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of aminopterin in treating patients who have refractory leukemia.
Study identification
- NCT ID
- NCT00003305
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 75 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 1997 (Type not available)
- Primary completion
- Not listed
- Completion
- Sep 2007 (Actual)
- Last update posted
- Jan 6, 2014
1997 – 2007
United States locations
- U.S. sites
- 14
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Urology Medical Center | Anaheim | California | 92801 | — |
| South Coast Urological Medical Group | Laguana Hills | California | 92653 | — |
| Urology Specialists, P.C. | Waterbury | Connecticut | 06708 | — |
| Barzell, Whitmore, Treiman and Dunne - The Urology Treatment Center | Sarasota | Florida | 34239 | — |
| University of Chicago Cancer Research Center | Chicago | Illinois | 60637 | — |
| 206 Research Associates | Greenbelt | Maryland | 20770 | — |
| Mid Atlantic Clinical Research | Rockville | Maryland | 20850 | — |
| Cancer Institute of New Jersey | New Brunswick | New Jersey | 08901 | — |
| Medical & Clinical Research Associates, LLC | Bay Shore | New York | 11706 | — |
| Herbert Irving Comprehensive Cancer Center | New York | New York | 10032 | — |
| Medical City Dallas Hospital | Dallas | Texas | 75230 | — |
| Urology Centers of North Texas | Dallas | Texas | 75231 | — |
| Urology San Antonio Research | San Antonio | Texas | 78229 | — |
| Children's Hospital and Regional Medical Center - Seattle | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00003305, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 6, 2014 · Synced Oct 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00003305 live on ClinicalTrials.gov.